Topics
- Influence of I.T. and Big Data on the laboratory
- Start-up to IPO: capitalising on scientific discovery
- Funding Science in an increasingly risk-averse market
- Drug pricing: Ethical and Business Challenges, and who should set them
- Penetrating new markets: traditional technology firms and healthcare
- Scientific and real-world benefits of collaboration
- Covering science in an increasingly educated and engaged age: the media perspective
Who should Attend
Experts from biopharma, academia, research institutions, healthcare and councils.
